MYCN and neoplasm: We have in this work further characterized the TH-MYCN model and detected specific differences in tumor incidence, time to tumor development and therapeutic window between mice hemizygous and homozygous for the TH-MYCN transgene, supporting the role of early and correct genotyping for future evaluation of targeted therapeutic interventions.